Skip to main content
Andy Cope
Andy Cope

Professor Andrew Cope

Professor of Rheumatology

  • Head of the Centre for Rheumatic Diseases

Research interests

  • Immunology

Contact details

Biography

Andrew Cope graduated in Medicine from the University of London with First Class Honours.

After training in general internal medicine at Northwick Park Hospital, The National Hospital for Nervous Diseases and the Royal Brompton Hospital, he trained in rheumatology with Professor Sir Ravinder Maini and Dr Barbara Ansell CBE.

In 1990, he was awarded a Wellcome Trust Clinical Training Fellowship, studying for a PhD in Cytokine Biology with Professor Marc Feldmann at the Kennedy Institute of Rheumatology. Following a postdoctoral fellowship with Prof Hugh McDevitt at Stanford University, California, studying transgenic models of autoimmunity, he returned to the Kennedy Institute to set up his own laboratory.

    Research

    OILRIG
    Lipids and Membranes Research Interest Group

    A Lipids and Membranes Research Interest Group

    News

    Clinical trial shows rheumatoid arthritis drug could prevent disease

    A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk.

    Arthritis-joint-pain-knee

    Just one in three people with gout prescribed preventative medication

    Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.

    Pill box, showing colourful pills for days of the week

    National trial launched to find Covid-19 treatment

    A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.

    covid hospital

    Centre for Rheumatic Diseases recognised as Centre for Excellence

    The Centre has been named by the European League Against Rheumatism (EULAR) as one of the top research centres in Europe for rheumatology research.

    busy hospital

      Research

      OILRIG
      Lipids and Membranes Research Interest Group

      A Lipids and Membranes Research Interest Group

      News

      Clinical trial shows rheumatoid arthritis drug could prevent disease

      A drug used to treat rheumatoid arthritis could also prevent the disease in individuals deemed to be at risk.

      Arthritis-joint-pain-knee

      Just one in three people with gout prescribed preventative medication

      Just one in three patients with gout in the UK received preventative medication within a year of diagnosis, new research has found.

      Pill box, showing colourful pills for days of the week

      National trial launched to find Covid-19 treatment

      A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by clinicians and scientists at King’s and in Cambridge.

      covid hospital

      Centre for Rheumatic Diseases recognised as Centre for Excellence

      The Centre has been named by the European League Against Rheumatism (EULAR) as one of the top research centres in Europe for rheumatology research.

      busy hospital